Shares of pharmaceutical giant Amgen (AMGN) are attempting to bounce back after suffering a steep drop of 7.1% yesterday.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Vertex has reached a key moment because the U.S. Food and Drug Administration (FDA) is reviewing its candidate, suzetrigine, ...

Mizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome when ...

An analyst from YES Securities said that Lupin has broken down from a descending triangle pattern on daily timeframe, ...

The 30-share BSE Sensex pack fell 111 points or 0.14 per cent to close at 77,580 and the broader NSE barometer Nifty hit ...

The Nifty Pharma index closed 0.26 per cent at 21752.00. Benchmark NSE Nifty50 index ended down 26.35 points at 23532.7, ...

We recently published a list of 10 Top Performing European Stocks Heading into 2025. In this article, we are going to take a ...

Syndax Pharmaceuticals announces positive Phase 2 trial results for revumenib in relapsed/refractory mNPM1 AML, with key ...

Corvus Pharmaceuticals, Inc. is headquartered just outside of ... and infectious diseases. The stock has rallied to just ...

Ascendis Pharma (ASND) has released an update. Ascendis Pharma A/S has structured its capital to enable significant growth opportunities, with ...

On Wednesday, Sigachi Industries Ltd. made its Q2FY25 and H1FY25 announcements. When compared to Q2FY24, when net revenues ...